The Pharma Marketer’s Roadmap: COVID-19 Insights & Recommendations

As the United States approaches nearly two million confirmed cases of COVID-19 and more than 105,000 deaths, communities are beginning to re-open, and people are starting to return to a somewhat normal life. Yet the healthcare industry is still coping with the changes the pandemic has forced — and many of these changes likely won’t be reversed. Where does pharma fit, and how can pharma marketers help healthcare providers (HCPs) and their patients get the information and the treatment options they need during a time of reduced access?